183 related articles for article (PubMed ID: 34956867)
1. Copy Number Alterations in Hepatoblastoma: Literature Review and a Brazilian Cohort Analysis Highlight New Biological Pathways.
Barros JS; Aguiar TFM; Costa SS; Rivas MP; Cypriano M; Toledo SRC; Novak EM; Odone V; Cristofani LM; Carraro DM; Werneck da Cunha I; Costa CML; Vianna-Morgante AM; Rosenberg C; Krepischi ACV
Front Oncol; 2021; 11():741526. PubMed ID: 34956867
[TBL] [Abstract][Full Text] [Related]
2. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.
Weber RG; Pietsch T; von Schweinitz D; Lichter P
Am J Pathol; 2000 Aug; 157(2):571-8. PubMed ID: 10934159
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.
Buendia MA
Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912
[TBL] [Abstract][Full Text] [Related]
4. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.
Sumazin P; Peters TL; Sarabia SF; Kim HR; Urbicain M; Hollingsworth EF; Alvarez KR; Perez CR; Pozza A; Najaf Panah MJ; Epps JL; Scorsone K; Zorman B; Katzenstein H; O'Neill AF; Meyers R; Tiao G; Geller J; Ranganathan S; Rangaswami AA; Woodfield SE; Goss JA; Vasudevan SA; Heczey A; Roy A; Fisher KE; Alaggio R; Patel KR; Finegold MJ; López-Terrada DH
J Hepatol; 2022 Oct; 77(4):1026-1037. PubMed ID: 35577029
[TBL] [Abstract][Full Text] [Related]
5. Virtual CGH: an integrative approach to predict genetic abnormalities from gene expression microarray data applied in lymphoma.
Geng H; Iqbal J; Chan WC; Ali HH
BMC Med Genomics; 2011 Apr; 4():32. PubMed ID: 21486456
[TBL] [Abstract][Full Text] [Related]
6. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
[TBL] [Abstract][Full Text] [Related]
7. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
[TBL] [Abstract][Full Text] [Related]
8. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.
Guo X; Yanna ; Ma X; An J; Shang Y; Huang Q; Yang H; Chen Z; Xing J
PLoS One; 2011; 6(12):e28404. PubMed ID: 22174799
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.
Kuglik P; Smetana J; Vallova V; Moukova L; Kasikova K; Cvanova M; Brozova L
Int J Clin Exp Pathol; 2014; 7(8):5071-82. PubMed ID: 25197380
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel genomic aberrations in AML-M5 in a level of array CGH.
Zhang R; Lee JY; Wang X; Xu W; Hu X; Lu X; Niu Y; Tang R; Li S; Li Y
PLoS One; 2014; 9(4):e87637. PubMed ID: 24727659
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast.
Fidalgo F; Rodrigues TC; Pinilla M; Silva AG; Maciel Mdo S; Rosenberg C; de Andrade VP; Carraro DM; Krepischi AC
Tumour Biol; 2015 Mar; 36(3):1835-48. PubMed ID: 25391423
[TBL] [Abstract][Full Text] [Related]
13. Correlating genomic copy number alterations with clinicopathologic findings in 75 cases of hepatocellular carcinoma.
Peng G; Chai H; Ji W; Lu Y; Wu S; Zhao H; Li P; Hu Q
BMC Med Genomics; 2021 Jun; 14(1):150. PubMed ID: 34103027
[TBL] [Abstract][Full Text] [Related]
14. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data.
Williams JL; Greer PA; Squire JA
Cancer Genet; 2014; 207(10-12):474-88. PubMed ID: 25434580
[TBL] [Abstract][Full Text] [Related]
15. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
16. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
Hawthorn L; Luce J; Stein L; Rothschild J
BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942
[TBL] [Abstract][Full Text] [Related]
17. Upregulated genes at 2q24 gains as candidate oncogenes in hepatoblastomas.
Rodrigues TC; Fidalgo F; da Costa CM; Ferreira EN; da Cunha IW; Carraro DM; Krepischi AC; Rosenberg C
Future Oncol; 2014 Dec; 10(15):2449-57. PubMed ID: 25525853
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomic hybridization analysis of hepatoblastoma reveals high frequency of X-chromosome gains and similarities between epithelial and stromal components.
Terracciano LM; Bernasconi B; Ruck P; Stallmach T; Briner J; Sauter G; Moch H; Vecchione R; Pollice L; Pettinato G; Gürtl B; Ratschek M; De Krijger R; Tornillo L; Bruder E
Hum Pathol; 2003 Sep; 34(9):864-71. PubMed ID: 14562281
[TBL] [Abstract][Full Text] [Related]
19. Genomic Alterations in Gastrointestinal Stromal Tumors as Revealed by Conventional and Array-based Comparative Genomic Hybridization.
Granitto SR; Kolachana P; Antonescu CR; Johnson RC; Dematteo RP; Jhanwar SC
Cancer Genomics Proteomics; 2004; 1(2):105-116. PubMed ID: 31394675
[TBL] [Abstract][Full Text] [Related]
20. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
